Company Profiles

driven by the PitchBook Platform

Admetsys

Admetsys
2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Corporate LATEST DEAL TYPE
9 FINANCING ROUNDS
Description

Developer of a blood-sugar management system designed to control blood sugar in Type-1 diabetes patients. The company's Automated Insulin Delivery (AID) system uses a standard IV line, which draws a small blood sample (less than a mL) every few minutes, from which it measures glucose electro-chemically and returns the blood back to the patient enabling hospitals to more effectively control blood glucose levels and alleviate some of the stresses associated with diabetic care in the hospital environment.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
21 Drydock Avenue
Suite 610E, 6th Floor
Boston, MA 02210
United States

Admetsys Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Admetsys‘s full profile, request access.

Request full access to PitchBook

Admetsys Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Admetsys‘s full profile, request access.

Request full access to PitchBook

Admetsys Executive Team (3)

Name Title Board
Seat
Contact
Info
Jeffrey Valk Co-Founder and Chief Executive Officer
Glenn Robertelli Chief Operating Officer & Co-Founder
Tim Valk MD Chief Scientist